| Accumulated other comprehensive income reflected on the Consolidated Balance Sheets |
The following table reflects changes in accumulated other comprehensive income/(loss) by component as of March 29, 2025 and September 28, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | | Cumulative Foreign Currency Translation Adjustment | | Pension Plan Adjustments | | Gain/(Loss) on Derivative Instruments | | Total | As of September 28, 2024 | | $ | (13,261) | | | $ | (1,682) | | | $ | 1,521 | | | $ | (13,422) | | Other comprehensive (loss)/income before reclassifications | | (7,401) | | | 79 | | | (2,071) | | | (9,393) | | Amount reclassified out of accumulated other comprehensive loss | | (815) | | | — | | | (128) | | | (943) | | | Tax effects | | 427 | | | — | | | — | | | 427 | | Other comprehensive (loss)/income | | (7,789) | | | 79 | | | (2,199) | | | (9,909) | | As of March 29, 2025 | | $ | (21,050) | | | $ | (1,603) | | | $ | (678) | | | $ | (23,331) | |
|
| Restricted stock and common stock granted |
The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three and six months ended March 29, 2025 and March 30, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | (shares in thousands) | March 29, 2025 | | March 30, 2024 | | March 29, 2025 | | March 30, 2024 | | Time-based RSUs | — | | | 3 | | | 563 | | | 502 | | | Relative TSR PSUs | — | | | — | | | 128 | | | 231 | | | Growth PSUs | — | | | — | | | — | | | 49 | | | Common stock | 7 | | | 6 | | | 14 | | | 13 | | | Equity-based compensation in shares | 7 | | | 9 | | | 705 | | | 795 | |
|
| Equity-based compensation expense |
The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and six months ended March 29, 2025 and March 30, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | (in thousands) | March 29, 2025 | | March 30, 2024 | | March 29, 2025 | | March 30, 2024 | | Cost of sales | $ | 387 | | | $ | 363 | | | $ | 770 | | | $ | 722 | | | Selling, general and administrative | 4,920 | | | 4,103 | | | 8,659 | | | 9,783 | | | Research and development | 2,186 | | | 1,766 | | | 4,205 | | | 3,584 | | | Total equity-based compensation expense | $ | 7,493 | | | $ | 6,232 | | | $ | 13,634 | | | $ | 14,089 | |
The following table reflects equity-based compensation expense, by type of award, for the three and six months ended March 29, 2025 and March 30, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | (in thousands) | March 29, 2025 | | March 30, 2024 | | March 29, 2025 | | March 30, 2024 | | Time-based RSUs | $ | 5,210 | | | $ | 4,470 | | | $ | 10,366 | | | $ | 9,013 | | | Relative TSR PSUs | 1,837 | | | 1,273 | | | 3,615 | | | 2,833 | | | Growth PSUs | 131 | | | 174 | | | (977) | | | 1,613 | | | | | | | | | | | Common stock | 315 | | | 315 | | | 630 | | | 630 | | | Total equity-based compensation expense | $ | 7,493 | | | $ | 6,232 | | | $ | 13,634 | | | $ | 14,089 | | | | | | | | | |
|